CasLoc logo
All Cases PTAB Litigations UPC Oppositions

HORIZON PHARMA IRELAND LIMITED v. LUPIN LTD.

1:16-cv-05054

Overview

Case Number 1:16-cv-05054
Filing Date 2016-08-18
Status Terminated
Termination Date 2018-06-19
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 15:1126 Patent Infringement
Jury Demand None

Parties

Defendant

LUPIN LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

HORIZON PHARMA IRELAND LIMITED NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2014-12-23
1:14-cv-07992

HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.

Asserted Patent
Status: NJD
U.S. District Court 2013-12-19
1:13-cv-02044

IGI Laboratories Inc. v. Mallinckrodt LLC

U.S. Family Sibling (["US8217078", "US8546450"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8741956
Treatment of pain with topical diclofenac
Filed: 2012-11-02
Issued: 2014-06-03
Active (6.0 yrs remaining)
Expires: 2032-11-02

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

39

Dispositive

22

Granted

10

Denied

1

Pending / Review

28

Motions by Category

Procedural / Extension Motion 16 Motion to Dismiss 9 Claim Construction / Markman Filing 1 Motion for Summary Judgment (Rule 56) 8 Motion for Summary Judgment (Infringement) 5

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
Order on Motion to Dismiss
Entry #173 • 2017-09-15 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by LUPIN LTD., LUPIN PHARMACEUTICALS INC. re 108 MOTION for Summary Judgment of Noninfringement (Attachments: # 1 Decl...
Entry #129 • 2017-06-26 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by All Plaintiffs re 115 Cross MOTION for Summary Judgment and Opposition to Plaintiffs' Motion for Summary Judgment a...
Entry #131 • 2017-06-26 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
ORDER the time to file redacted versions of briefing related to Lupin's Motion for Summary Judgment of Non-Infringement, including the reply brief, be extended ...
Entry #128 • 2017-06-21 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
BRIEF in Opposition filed by All Plaintiffs re 108 MOTION for Summary Judgment of Noninfringement (Attachments: # 1 Statement Horizons Statement of Material Fac...
Entry #124 • 2017-06-19 Document →
Motion to Dismiss Pending / Under Review
ORDER that Plaintiffs' request for a stay of discovery pending the District Court's resolution of Plaintiffs' motion to dismiss shall be, and is hereby, DENIED....
Entry #121 • 2017-06-13 Document →

Docket Entries

(286 total)
Pleading / Complaint

COMPLAINT against LUPIN LTD., LUPIN PHARMACEUTICALS INC. ( Filing and Admin fee $ 400 receipt number 0312-7299614), filed by HORIZON PHARMA IRELAND LIMITED, HORIZON PHARMA USA, INC., HZNP LIMITED. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(FLAHERTY, JOHN) (Entered: 08/18/2016)

Entry #1 • 2016-08-18
1

Corporate Disclosure Statement by HORIZON PHARMA IRELAND LIMITED, HORIZON PHARMA USA, INC., HZNP LIMITED identifying Horizon Pharma plc as Corporate Parent.. (FLAHERTY, JOHN) (Entered: 08/18/2016)

Entry #2 • 2016-08-18
1

AO120 Patent/Trademark Form filed. (rtm, ) (Entered: 08/18/2016)

Entry #3 • 2016-08-18
1

SUMMONS ISSUED as to LUPIN LTD., LUPIN PHARMACEUTICALS INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Ryan Merrigan* (rtm, ) (Entered: 08/18/2016)

Entry #4 • 2016-08-18
1

NOTICE of Appearance by RAVIN R. PATEL on behalf of HORIZON PHARMA IRELAND LIMITED, HORIZON PHARMA USA, INC., HZNP LIMITED (PATEL, RAVIN) (Entered: 08/18/2016)

Entry #5 • 2016-08-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc